BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Serrano PE, Gu C, Husien M, Jalink D, Ritter A, Martel G, Tsang ME, Law CH, Hallet J, Mcalister V, Sela N, Solomon H, Moulton C, Gallinger S, Levine M. Risk factors for survival following recurrence after first liver resection for colorectal cancer liver metastases. J Surg Oncol 2019;120:1420-6. [DOI: 10.1002/jso.25735] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Huang L, Tang X, Fang J, Zheng Z, Wei H. Synchronous Colorectal Liver Metastases considering Infectious Complications: Simultaneous or Delayed Surgery? Evid Based Complement Alternat Med 2022;2022:5268554. [PMID: 36267088 DOI: 10.1155/2022/5268554] [Reference Citation Analysis]
2 Chen Q, Zhang R, Xing B, Li C, Xiu D, Chen J, Deng Y, Chen X, Guo R, Chen F, Peng J, Sun T, Wang H, Li M, Zheng Q, Bi X, Zhao J, Zhou J, Li Z, Huang Z, Zhang Y, Zhang Y, Cai J, Zhao H. Optimal surgical sequence for colorectal cancer liver metastases patients receiving colorectal cancer resection with simultaneous liver metastasis resection: A multicentre retrospective propensity score matching study. International Journal of Surgery 2022;106:106952. [DOI: 10.1016/j.ijsu.2022.106952] [Reference Citation Analysis]
3 Callesen LB, Hansen TF, Andersen RF, Pallisgaard N, Kramer S, Schlander S, Rafaelsen SR, Boysen AK, Jensen LH, Jakobsen A, Spindler KG. OPTIMISE: Optimisation of treatment selection and follow-up in oligometastatic colorectal cancer - a ctDNA-guided phase II randomised approach. Study protocol. Acta Oncol 2022;:1-5. [PMID: 36094310 DOI: 10.1080/0284186X.2022.2116728] [Reference Citation Analysis]
4 Chen Q, Zhang Y, Deng Y, Huang Z, Zhao H, Cai J. Outcomes of simultaneous resection for elderly patients with colorectal liver metastasis: A propensity score matching analysis. Cancer Med 2022;11:4913-26. [PMID: 35608250 DOI: 10.1002/cam4.4826] [Reference Citation Analysis]
5 Serrano PE, Parpia S, Karanicolas P, Gallinger S, Wei AC, Simunovic M, Bhandari M, Levine M. Simultaneous resection for synchronous colorectal cancer liver metastases: A feasibility clinical trial. J Surg Oncol 2022;125:671-7. [PMID: 34878649 DOI: 10.1002/jso.26764] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
6 Park LJ, Daza JF, Li V, Workneh A, Zuk V, Claasen MPA, Hallet J, Martel G, Sapisochin G, Serrano PE. Prognostic factors of overall survival in patients with recurrent disease following liver resection for colorectal cancer metastases: A multicenter external validation study. Journal of Surgical Oncology. [DOI: 10.1002/jso.26796] [Reference Citation Analysis]
7 Liu W, Liu JM, Wang K, Wang HW, Xing BC. Recurrent colorectal liver metastasis patients could benefit from repeat hepatic resection. BMC Surg 2021;21:327. [PMID: 34399728 DOI: 10.1186/s12893-021-01323-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
8 Hellingman T, Kuiper BI, Buffart LM, Meijerink MR, Versteeg KS, Swijnenburg RJ, van Delden OM, Haasbeek CJA, de Vries JJJ, van Waesberghe JHTM, Zonderhuis BM, van der Vliet HJ, Kazemier G. Survival Benefit of Repeat Local Treatment in Patients Suffering From Early Recurrence of Colorectal Cancer Liver Metastases. Clin Colorectal Cancer 2021:S1533-0028(21)00072-4. [PMID: 34462211 DOI: 10.1016/j.clcc.2021.07.007] [Reference Citation Analysis]
9 Wu X, Wang Q, Lu Y, Zhang J, Yin H, Yi Y. Clinical application of thioredoxin reductase as a novel biomarker in liver cancer. Sci Rep 2021;11:6069. [PMID: 33727662 DOI: 10.1038/s41598-021-85688-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
10 Liang JY, Lin HC, Liu J, Wang DS, Yuan YF, Li BK, Zheng Y, Wu XJ, Chen G, Wang FH, Wang ZQ, Pan ZZ, Wan DS, Xu RH, Li YH. A novel prognostic nomogram for colorectal cancer liver metastasis patients with recurrence after hepatectomy. Cancer Med 2021;10:1535-44. [PMID: 33539664 DOI: 10.1002/cam4.3697] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Joharatnam-Hogan N, Wilson W, Shiu KK, Fusai GK, Davidson B, Hochhauser D, Bridgewater J, Khan K. Multimodal Treatment in Metastatic Colorectal Cancer (mCRC) Improves Outcomes-The University College London Hospital (UCLH) Experience. Cancers (Basel) 2020;12:E3545. [PMID: 33261002 DOI: 10.3390/cancers12123545] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
12 Hajibandeh S, Hajibandeh S, Sultana A, Ferris G, Mwendwa J, Mohamedahmed AYY, Zaman S, Peravali R. Simultaneous versus staged colorectal and hepatic resections for colorectal cancer with synchronous hepatic metastases: a meta-analysis of outcomes and clinical characteristics. Int J Colorectal Dis 2020;35:1629-50. [PMID: 32653951 DOI: 10.1007/s00384-020-03694-9] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
13 Matteo B, Gaetano P, Delfina T, Riccardo M, Roberto S, Guglielmo P, Claudia C, Carmelo L, Carla C, Daris F, Maria IA, Gaetano B, Carrafiello G, Enrico O. Immunohistochemical evaluation of microsatellite instability in resected colorectal liver metastases: a preliminary experience. Med Oncol 2020;37:63. [PMID: 32556620 DOI: 10.1007/s12032-020-01388-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
14 Pirini F, Pasini L, Tedaldi G, Scarpi E, Marisi G, Molinari C, Calistri D, Passardi A, Ulivi P. Instability of Non-Standard Microsatellites in Relation to Prognosis in Metastatic Colorectal Cancer Patients. Int J Mol Sci 2020;21:E3532. [PMID: 32429465 DOI: 10.3390/ijms21103532] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
15 Ochoa-hernandez A, Giron K, Meier J, Charchalac AP. Current Options in the Management of Colorectal Cancer in Developing Countries: Central America Experience. Curr Colorectal Cancer Rep 2020;16:49-54. [DOI: 10.1007/s11888-020-00452-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
16 Wang J, Griffiths C, Simunovic M, Parpia S, Gu CS, Gafni A, Ruo L, Hallet J, Bogach J, Serrano PE. Simultaneous versus staged resection for synchronous colorectal liver metastases: A population-based cost analysis in Ontario, Canada - Health economic evaluation. Int J Surg 2020;78:75-82. [PMID: 32335234 DOI: 10.1016/j.ijsu.2020.04.044] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
17 Yang J, Liu SY, Liu YD. Integrated bioinformatics analysis of expression, related signal pathways, and prognostic significance of CCNA2 in hepatocellular carcinoma. Shijie Huaren Xiaohua Zazhi 2019; 27(24): 1490-1501 [DOI: 10.11569/wcjd.v27.i24.1490] [Cited by in CrossRef: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
18 Bogach J, Wang J, Griffiths C, Parpia S, Saskin R, Hallet J, Ruo L, Simunovic M, Serrano PE. Simultaneous versus staged resection for synchronous colorectal liver metastases: A population-based cohort study. Int J Surg. 2020;74:68-75. [PMID: 31843676 DOI: 10.1016/j.ijsu.2019.12.009] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 4.5] [Reference Citation Analysis]